Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2006 | 1 |
2008 | 1 |
2009 | 1 |
2010 | 1 |
2011 | 2 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Cancer immunotherapy targeting the telomerase reverse transcriptase.
Cell Mol Immunol. 2006 Feb;3(1):1-11.
Cell Mol Immunol. 2006.
PMID: 16549043
Free article.
Review.
Effective melanoma immunotherapy with interleukin-2 delivered by a novel polymeric nanoparticle.
Yao H, Ng SS, Huo LF, Chow BK, Shen Z, Yang M, Sze J, Ko O, Li M, Yue A, Lu LW, Bian XW, Kung HF, Lin MC.
Yao H, et al. Among authors: huo lf.
Mol Cancer Ther. 2011 Jun;10(6):1082-92. doi: 10.1158/1535-7163.MCT-10-0717. Epub 2011 Apr 25.
Mol Cancer Ther. 2011.
PMID: 21518728
Item in Clipboard
AAV-HGFK1 and Ad-p53 cocktail therapy prolongs survival of mice with colon cancer.
Nie B, Shen Z, Wen JB, Wong OG, Hsueh WD, Huo LF, Kung HF, Jiang B, Lin MC.
Nie B, et al. Among authors: huo lf.
Mol Cancer Ther. 2008 Sep;7(9):2855-65. doi: 10.1158/1535-7163.MCT-08-0366.
Mol Cancer Ther. 2008.
PMID: 18790766
Free article.
Item in Clipboard
Acetylation of EGF receptor contributes to tumor cell resistance to histone deacetylase inhibitors.
Song H, Li CW, Labaff AM, Lim SO, Li LY, Kan SF, Chen Y, Zhang K, Lang J, Xie X, Wang Y, Huo LF, Hsu SC, Chen X, Zhao Y, Hung MC.
Song H, et al. Among authors: huo lf.
Biochem Biophys Res Commun. 2011 Jan 7;404(1):68-73. doi: 10.1016/j.bbrc.2010.11.064. Epub 2010 Nov 19.
Biochem Biophys Res Commun. 2011.
PMID: 21094134
Free PMC article.
Item in Clipboard
Nuclear expression of epidermal growth factor receptor is a novel prognostic value in patients with ovarian cancer.
Xia W, Wei Y, Du Y, Liu J, Chang B, Yu YL, Huo LF, Miller S, Hung MC.
Xia W, et al. Among authors: huo lf.
Mol Carcinog. 2009 Jul;48(7):610-7. doi: 10.1002/mc.20504.
Mol Carcinog. 2009.
PMID: 19058255
Free PMC article.
Item in Clipboard
Cite
Cite